Institute of Cardiovascular Sciences We are leaders in cardiovascular research, including atrial fibrillation and heart failure, thrombosis and haemostasis, and vascular biology.
News AI in cardiology: A step-by-step guide to developing high-quality algorithms Artificial intelligence (AI) has been one of the biggest stories in healthcare for years, but many clinicians still remain unsure about how, exactly, they should be using AI to help their patients
News Dr Pavlovic appointed as Editor in Chief of the Journal of Molecular and Cellular Cardiology PLUS
News Heart surgery and impact on mental health among new priorities for congenital heart disease research
10 January 2023 Dr Pavlovic appointed as Editor in Chief of the Journal of Molecular and Cellular Cardiology PLUS JMCC PLUS publishes fundamental and translational research that advances knowledge of the mechanisms for normal and diseased cardiovascular function.
13 December 2022 Blood clotting research holds hope for sepsis Researchers who identified a novel mechanism for platelet activation in blood clotting (thrombosis) are now turning their attention to sepsis
12 December 2022 Heart surgery and impact on mental health among new priorities for congenital heart disease research Patients, parents, charities and healthcare professionals agree key focuses for future research for disease affecting around half a million in UK
02 December 2022 Abnormal heartbeat identified in 1 in 20 older adults using wrist-worn wearable and smartphone A new study, conducted by the Atrial Fibrillation NETwork (AFNET), offered smartphone and arrhythmia screening to older adults without atrial fibrillation.
23 November 2022 World’s first clinical trial to test new drug glenzocimab for heart attacks New partnership with Acticor Biotech will see patients with heart attacks treated with glenzocimab, a promising new class of drug for the first time.
15 November 2022 Researchers make miniature ‘bone marrows in a dish’ to improve anti-cancer treatments The organoids provide a micro-environment that can accept and support the survival of cells from patients with blood malignancies
20 October 2022 Dr Gill Lowe appointed as national haematology lead at NIHR Dr Gill Lowe in the Institute of Cardiovascular Sciences, University of Birmingham has been appointed National Haematology Specialty Lead